140 related articles for article (PubMed ID: 24997618)
1. The effect of TLX3 expression on the prognosis of pediatric T cell acute lymphocytic leukemia--a systematic review.
Ma J; Hua J; Sha Y; Xie Y
Tumour Biol; 2014 Sep; 35(9):8439-43. PubMed ID: 24997618
[TBL] [Abstract][Full Text] [Related]
2. The indicative effect of Notch1 expression for the prognosis of T-cell acute lymphocytic leukemia: a systematic review.
Ma J; Wu M
Mol Biol Rep; 2012 May; 39(5):6095-100. PubMed ID: 22311010
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of TLX3 (HOX11L2) expression in childhood T-cell acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing early and late re-intensification elements.
Attarbaschi A; Pisecker M; Inthal A; Mann G; Janousek D; Dworzak M; Pötschger U; Ullmann R; Schrappe M; Gadner H; Haas OA; Panzer-Grümayer R; Strehl S;
Br J Haematol; 2010 Jan; 148(2):293-300. PubMed ID: 19821827
[TBL] [Abstract][Full Text] [Related]
4. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
5. An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
Bond J; Marchand T; Touzart A; Cieslak A; Trinquand A; Sutton L; Radford-Weiss I; Lhermitte L; Spicuglia S; Dombret H; Macintyre E; Ifrah N; Hamel JF; Asnafi V
Haematologica; 2016 Jun; 101(6):732-40. PubMed ID: 26944475
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotyping with CD135 and CD117 predicts the FLT3, IL-7R and TLX3 gene mutations in childhood T-cell acute leukemia.
Noronha EP; Andrade FG; Zampier C; de Andrade CF; Terra-Granado E; Pombo-de-Oliveira MS;
Blood Cells Mol Dis; 2016 Mar; 57():74-80. PubMed ID: 26852660
[TBL] [Abstract][Full Text] [Related]
7. NKX2-5, SIL/TAL and TLX3/HOX11L2 expression in Egyptian pediatric T-cell acute lymphoblastic leukemia.
Moussa H; Sidhom I
Asia Pac J Clin Oncol; 2016 Mar; 12(1):e1-10. PubMed ID: 24571118
[TBL] [Abstract][Full Text] [Related]
8. The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Larson Gedman A; Chen Q; Kugel Desmoulin S; Ge Y; LaFiura K; Haska CL; Cherian C; Devidas M; Linda SB; Taub JW; Matherly LH
Leukemia; 2009 Aug; 23(8):1417-25. PubMed ID: 19340001
[TBL] [Abstract][Full Text] [Related]
9. Absence of biallelic TCRγ deletion predicts induction failure and poorer outcomes in childhood T-cell acute lymphoblastic leukemia.
Yang YL; Hsiao CC; Chen HY; Lin KH; Jou ST; Chen JS; Chang TK; Sheen JM; Yu SL; Lu MY; Cheng CN; Wu KH; Wang SC; Wang JD; Chang HH; Lin SR; Lin SW; Lin DT
Pediatr Blood Cancer; 2012 Jun; 58(6):846-51. PubMed ID: 22180181
[TBL] [Abstract][Full Text] [Related]
10. ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia.
Peirs S; Matthijssens F; Goossens S; Van de Walle I; Ruggero K; de Bock CE; Degryse S; Canté-Barrett K; Briot D; Clappier E; Lammens T; De Moerloose B; Benoit Y; Poppe B; Meijerink JP; Cools J; Soulier J; Rabbitts TH; Taghon T; Speleman F; Van Vlierberghe P
Blood; 2014 Dec; 124(25):3738-47. PubMed ID: 25301704
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of leukemia-induced non-coding activator RNA (LUNAR1) predicts poor outcome in pediatric T-acute lymphoblastic leukemia.
El-Khazragy N; Abdel Aziz MA; Hesham M; Matbouly S; Mostafa SA; Bakkar A; Abouelnile M; Noufal Y; Mahran NA; Abd Elkhalek MA; Abdelmaksoud MF
Immunobiology; 2021 Nov; 226(6):152149. PubMed ID: 34735923
[TBL] [Abstract][Full Text] [Related]
12. [Outcome of children with T cell acute lymphoblastic leukemia treated with Chinese Children Leukemia Group acute lymphoblastic leukemia (CCLG-ALL) 2008 protocol].
Liu XM; Chen XJ; Zou Y; Wang SC; Wang M; Zhang L; Chen YM; Yang WY; Guo Y; Zhu XF
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):761-766. PubMed ID: 31594062
[No Abstract] [Full Text] [Related]
13. The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia.
Zuurbier L; Petricoin EF; Vuerhard MJ; Calvert V; Kooi C; Buijs-Gladdines JG; Smits WK; Sonneveld E; Veerman AJ; Kamps WA; Horstmann M; Pieters R; Meijerink JP
Haematologica; 2012 Sep; 97(9):1405-13. PubMed ID: 22491738
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL.
Touzart A; Lengliné E; Latiri M; Belhocine M; Smith C; Thomas X; Spicuglia S; Puthier D; Pflumio F; Leguay T; Graux C; Chalandon Y; Huguet F; Leprêtre S; Ifrah N; Dombret H; Macintyre E; Hunault M; Boissel N; Asnafi V
Clin Cancer Res; 2019 Apr; 25(8):2483-2493. PubMed ID: 30659025
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of FLT3 ITD mutation on the prognosis of adult acute promyelocytic leukemia.
Fan Y; Cao Y; Bai X; Zhuang W
Hematology; 2018 Aug; 23(7):379-384. PubMed ID: 29251252
[TBL] [Abstract][Full Text] [Related]
16. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols.
Zuurbier L; Homminga I; Calvert V; te Winkel ML; Buijs-Gladdines JG; Kooi C; Smits WK; Sonneveld E; Veerman AJ; Kamps WA; Horstmann M; Petricoin EF; Pieters R; Meijerink JP
Leukemia; 2010 Dec; 24(12):2014-22. PubMed ID: 20861909
[TBL] [Abstract][Full Text] [Related]
17. SIL-TAL1 fusion gene negative impact in T-cell acute lymphoblastic leukemia outcome.
Mansur MB; Emerenciano M; Brewer L; Sant'Ana M; Mendonça N; Thuler LC; Koifman S; Pombo-de-Oliveira MS
Leuk Lymphoma; 2009 Aug; 50(8):1318-25. PubMed ID: 19562638
[TBL] [Abstract][Full Text] [Related]
18. Significance of HOX11L2/TLX3 expression in children with T-cell acute lymphoblastic leukemia treated on Children's Cancer Group protocols.
Gottardo NG; Jacoby PA; Sather HN; Reaman GH; Baker DL; Kees UR
Leukemia; 2005 Sep; 19(9):1705-8. PubMed ID: 15990867
[No Abstract] [Full Text] [Related]
19. An integrated transcriptome analysis in T-cell acute lymphoblastic leukemia links DNA methylation subgroups to dysregulated TAL1 and ANTP homeobox gene expression.
Haider Z; Larsson P; Landfors M; Köhn L; Schmiegelow K; Flaegstad T; Kanerva J; Heyman M; Hultdin M; Degerman S
Cancer Med; 2019 Jan; 8(1):311-324. PubMed ID: 30575306
[TBL] [Abstract][Full Text] [Related]
20. 3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia.
Yang L; Chen F; Zhu H; Chen Y; Dong B; Shi M; Wang W; Jiang Q; Zhang L; Huang X; Zhang MQ; Wu H
Nat Commun; 2021 Jun; 12(1):3708. PubMed ID: 34140506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
